The compound is identical to the lyophilized vial format
Sikiric, P., et al., A behavioural study of the effect of pentadecapeptide BPC 157 in Parkinson's disease models in mice and gastric lesions induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydrophyridine
Visit our conveniently located clinic in San Antonio to quickly revitalize your energy and get back to living your absolute best life starting right now
BPC 157 10 g/kg, intraperitoneally or per-orally, was given with l-NAME (5 mg/kg intraperitoneally) and/or L-arginine (100 mg/kg intraperitoneally) and it maintained its original beneficial effect
Although it is not approved for human use by any major regulatory body, interest in NNMT inhibition as a research target has driven study of 5-Amino-1MQ in metabolic models
After 28 days, peptide degradation accelerates and potency drops below acceptable levels